Sage Journals: Discover world-class research

Open access

Review article

First published 2023

Real-world dose reduction of standard and modified FOLFIRINOX in metastatic pancreatic cancer: a systematic review,evidence-mapping,and meta-analysis

Kwangrok Jung, Suhyun Choi, Hyunjoo Song [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2020

FOLFIRINOX after first-line gemcitabine-based chemotherapy in advanced pancreatic cancer: a retrospective comparison with FOLFOX and FOLFIRI schedules

Francesca Foschini, Fabiana Napolitano, Alberto Servetto [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2023-12

Impact of Granulocyte Colony-Stimulating Factor (G-CSF) on the Outcomes of Patients With Metastatic Pancreatic Adenocarcinoma (MPA) During First-Line Treatment With FOLFIRINOX: A Single-Center Retrospective Analysis

Angelo Borsarelli Carvalho de Brito, Rachel P Riechelmann, Victor Hugo Fonseca de Jesus

Cancer Control

Open access

Research article

First published 2022-10

Induction Chemotherapy With FOLFIRINOX Followed by Chemoradiation With Gemcitabine in Patients With Borderline-Resectable Pancreatic Ductal Adenocarcinoma

Ana Acuna-Villaorduna, Viswanathan Shankar, Michael Wysota [...]

Cancer Control

Open access

Research article

First published 2020

Efficacy and safety of second-line nab-paclitaxel plus gemcitabine after progression on FOLFIRINOX for unresectable or metastatic pancreatic ductal adenocarcinoma: multicenter retrospective analysis

Heejung Chae, Hyehyun Jeong, Jaekyung Cheon [...]

Therapeutic Advances in Medical Oncology

Open access

Review article

First published 2024

Integration of liposomal irinotecan in the first-line treatment of metastatic pancreatic cancer: try to do not think about the white bear

Davide Melisi, Simona Casalino, Silvia Pietrobono [...]

Therapeutic Advances in Medical Oncology

Open access

Review article

First published 2021

Updates on adjuvant and neoadjuvant treatment strategies for surgically resectable and borderline resectable pancreatic ductal adenocarcinoma

Siddharth Iyengar, Christopher Nevala-Plagemann, Ignacio Garrido-Laguna

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2025

Real-world outcomes of fluorouracil-based second-line therapy in patients with advanced biliary tract cancer refractory to gemcitabine and cisplatin-based treatment

Se Jun Park, Kabsoo Shin, Hyunho Kim [...]

Therapeutic Advances in Medical Oncology

Free access

Review article

First published 2017-3

Liposomal irinotecan in gemcitabine-refractory metastatic pancreatic cancer: efficacy,safety and place in therapy

Emma Kipps, Kate Young, Naureen Starling

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2023

Efficacy and safety of SOXIRI versus mFOLFIRINOX in advanced pancreatic cancer

Xujia Li, Jinsheng Huang, Fenghua Wang [...]

Therapeutic Advances in Medical Oncology

Search results